Niveus Medical, a Palo Alto, Calif.-based developer of a series of novel technologies to reduce or prevent debilitation and thereby accelerate patient recovery, shorten hospital stays, and reduce both hospital and payer costs, has raised approximately $2m in Series A funding.
Investors include HealthTech Capital members, which committed $600k, Band of Angels, Life Science Angels, Sand Hill Angels, and other angel and venture capital groups.
The company intends to use the funds to validate the benefits ot its technology.
Led by CEO Brian J. Fahey, Niveus Medical is developing a technology to preserve muscle strength during long periods of sedation and bed rest.
FinSMEs
15/09/2011